Pulmonary vascular system: A vulnerable target for COVID‐19-Reference-Cited by-同舟云学术

Pulmonary vascular system: A vulnerable target for COVID‐19

Published:2021-10-17 Issue:4 Volume:2 Page:531-547
ISSN:2688-2663
Container-title:MedComm
language:en
Short-container-title:MedComm

Author:

Ai Jiayuan¹,Hong Weiqi¹^ORCID,Wu Min²,Wei Xiawei¹^ORCID

Affiliation:

1. Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy National Clinical Research Center for Geriatrics West China Hospital Sichuan University Chengdu Sichuan PR China

2. Department of Biomedical Sciences School of Medicine and Health Sciences University of North Dakota Grand Forks North Dakota USA

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mco2.94

Reference154 articles.

1. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

2. World Health Organization.Coronavirus disease (COVID‐2019) situation reports.https://www.who.int/data#reports. Accessed September 17 2021.

3. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches

4. The molecular assessment of SARS-CoV-2 Nucleocapsid Phosphoprotein variants among Indian isolates

5. COVID-19-associated vasculitis and vasculopathy

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of mitochondrial dynamics in disease;MedComm;2023-12

2. Pulmonary embolism in COVID-19 pneumonia patients admitted to temporary hospital - The follow-up study;Advances in Medical Sciences;2023-09

3. Dual-Source Photon-Counting Computed Tomography—Part III: Clinical Overview of Vascular Applications beyond Cardiac and Neuro Imaging;Journal of Clinical Medicine;2023-05-31

4. Mapping CircRNA–miRNA–mRNA regulatory axis identifies hsa_circ_0080942 and hsa_circ_0080135 as a potential theranostic agents for SARS-CoV-2 infection;PLOS ONE;2023-04-13

5. Increased circulating microparticles contribute to severe infection and adverse outcomes of COVID-19 in patients with diabetes;American Journal of Physiology-Heart and Circulatory Physiology;2022-12-01